
The goal of this study was to see how mitochondrial targeted antioxidants (mitoAOXs) affected glycaemic management, cardiovascular health, and oxidative stress in people. While short-term trials show that mitoAOXs are generally well tolerated, there is currently insufficient data to support their use in the management of glycemic control and cardiovascular health. Future research should focus on the impact of mitoAOXs on glycaemic management and endothelial function in target clinical demographic groups, according to the conclusions of the review.
Like
Save
Share